Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Brainxell Inc Terminally differentiated human cortical glutamatergic neurons; Derived from iPSC line WC-30, male. No known neurological or psychiatric disorders. Contents: 1 vial of ≥1x10^6 viable cryopreserved cells
Supplier: Brainxell Inc BX0300301M
Marker Expression: Cortical Glutamatergic Neurons (BX-0300) have high neuronal purity (>80%) and comprise predominantly excitatory neurons. Labeling with the pan-neuronal marker MAP2 (red) highlights the neuronal purity of these cells. Labeling with the glutamatergic-specific marker FOXP2 indicates the overwhelming presence of glutamatergic neurons. Function: Cortical Glutamatergic Neurons exhibit pronounced electrophysiological activity after two weeks in culture, as demonstrated by multi-electrode array (MEA) recordings. Related diseases: Alzheimer’s & Huntington’s Disease. Primary neurotransmitter released: Glutamate
This item is not returnable.
View return policy
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?